文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

前瞻性脓毒症与脓毒性休克队列中初始晶体液复苏时机模式及相关结局

Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论脓毒症识别后30分钟内启动晶体液复苏与住院死亡率降低相关(校正OR 0.76,95%CI 0.64-0.90),合并症与病情严重度不改变该效应。

该研究为连续样本观察性队列,纳入9家三级与社区医院1.5年内11182例成人脓毒症与脓毒性休克患者,评估脓毒症识别后启动晶体液的时间(≤30分钟、31-120分钟、>120分钟)与住院死亡率、机械通气、ICU使用及住院时长的关联。结果显示48%患者在≤30分钟内启动晶体液,21%在31-120分钟,31%在>120分钟;≤30分钟组死亡率最低(17.8%),31-120分钟组18.7%,>120分钟组24.5%。与>120分钟相比,≤30分钟组校正死亡OR为0.76(95%CI 0.64-0.90,P=0.002),31-120分钟组OR为0.76(95%CI 0.62-0.92,P=0.004);按连续时间评估,每延迟1小时启动死亡 odds 增加1.09(95%CI 1.03-1.16,P=0.002)。机械通气、ICU使用和住院时长呈相似模式,且启动时间与基线心衰、肾衰、低血压、急性肾损伤、气体交换异常或急诊就诊之间未见显著交互作用。

要点

  • 脓毒症识别后≤30分钟启动晶体液者住院死亡率17.8%,>120分钟者24.5%,校正OR 0.76(95%CI 0.64-0.90)。
  • 每延迟1小时启动晶体液,死亡 odds 增加1.09(95%CI 1.03-1.16,P=0.002)。
  • 合并心衰(β +20分钟,95%CI 14-25)和肾衰(β +16分钟,95%CI 10-22)时晶体液启动更慢。
  • 急诊就诊(β -141分钟,95%CI -159至-125)和基线低血压(β -39分钟,95%CI -48至-32)时晶体液启动更快。
  • 启动时间与基线心衰、肾衰、低血压、急性肾损伤、气体交换异常或急诊就诊之间未见显著交互作用。

适用人群与场景

  • 成人脓毒症与脓毒性休克患者,来自9家三级与社区医院1.5年内的连续样本观察性队列,纳入前瞻性质量改进数据库。
  • 纳入标准:疑似或确认感染、≥2项全身炎症反应标准、≥1项器官功能障碍标准。

诊断标准与关键阈值

  • 脓毒症识别基于纳入标准:疑似或确认感染、≥2项全身炎症反应标准、≥1项器官功能障碍标准。
  • 主要暴露分组:晶体液启动时间≤30分钟、31-120分钟、>120分钟(自脓毒症识别起算)。

研究设计与关键结果

  • 连续样本观察性队列,9家三级与社区医院,1.5年,纳入11182例成人脓毒症与脓毒性休克患者。
  • 晶体液启动时间分布:≤30分钟5336例(48%),31-120分钟2388例(21%),>120分钟3458例(31%)。
  • 住院死亡率:≤30分钟组949例(17.8%),31-120分钟组446例(18.7%),>120分钟组846例(24.5%)。
  • 与>120分钟相比,≤30分钟组校正死亡OR 0.76(95%CI 0.64-0.90,P=0.002),31-120分钟组OR 0.76(95%CI 0.62-0.92,P=0.004)。
  • 按连续时间评估,每延迟1小时启动晶体液,死亡 odds 增加1.09(95%CI 1.03-1.16,P=0.002)。
  • 机械通气、ICU使用和住院时长呈相似模式。
  • 启动时间与基线心衰、肾衰、低血压、急性肾损伤、气体交换异常或急诊就诊(vs 住院)之间未见显著交互作用。

证据类型、等级与局限

  • 证据类型:连续样本观察性队列(前瞻性质量改进数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:更早启动晶体液与死亡率降低相关,合并症与病情严重度不改变该效应。
  • 晶体液启动在合并心衰和肾衰、无发热或低血压、以及住院期间发生脓毒症的患者中显著更晚。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The objectives of this study were to 1) assess patterns of early crystalloid resuscitation provided to sepsis and septic shock patients at initial presentation and 2) determine the association between time to initial crystalloid resuscitation with hospital mortality, mechanical ventilation, ICU utilization, and length of stay.

DESIGN: Consecutive-sample observational cohort.

SETTING: Nine tertiary and community hospitals over 1.5 years.

PATIENTS: Adult sepsis and septic shock patients captured in a prospective quality improvement database inclusion criteria: suspected or confirmed infection, greater than or equal to two systemic inflammatory response criteria, greater than or equal to one organ-dysfunction criteria.

INTERVENTIONS: The primary exposure was crystalloid initiation within 30 minutes or lesser, 31-120 minutes, or more than 120 minutes from sepsis identification.

MEASUREMENTS AND MAIN RESULTS: We identified 11,182 patients. Crystalloid initiation was faster for emergency department patients (β, -141 min; CI, -159 to -125; p < 0.001), baseline hypotension (β, -39 min; CI, -48 to -32; p < 0.001), fever, urinary or skin/soft-tissue source of infection. Initiation was slower with heart failure (β, 20 min; CI, 14-25; p < 0.001), and renal failure (β, 16 min; CI, 10-22; p < 0.001). Five thousand three hundred thirty-six patients (48%) had crystalloid initiated in 30 minutes or lesser versus 2,388 (21%) in 31-120 minutes, and 3,458 (31%) in more than 120 minutes. The patients receiving fluids within 30 minutes had lowest mortality (949 [17.8%]) versus 31-120 minutes (446 [18.7%]) and more than 120 minutes (846 [24.5%]). Compared with more than 120 minutes, the adjusted odds ratio for mortality was 0.76 (CI, 0.64-0.90; p = 0.002) for 30 minutes or lesser and 0.76 (CI, 0.62-0.92; p = 0.004) for 31-120 minutes. When assessed continuously, mortality odds increased by 1.09 with each hour to initiation (CI, 1.03-1.16; p = 0.002). We observed similar patterns for mechanical ventilation, ICU utilization, and length of stay. We did not observe significant interaction for mortality risk between initiation time and baseline heart failure, renal failure, hypotension, acute kidney injury, altered gas exchange, or emergency department (vs inpatient) presentation.

CONCLUSIONS: Crystalloid was initiated significantly later with comorbid heart failure and renal failure, with absence of fever or hypotension, and in inpatient-presenting sepsis. Earlier crystalloid initiation was associated with decreased mortality. Comorbidities and severity did not modify this effect.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Leisman DE, Goldman C, Doerfler ME, et al. Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort. Crit Care Med. 2017. PMID: 28671898. doi:10.1097/CCM.0000000000002574

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。